STAT
JUNE 19, 2023
James Boone wakes up at 6 a.m. nearly every Sunday, driving his van to Trader Joe’s and other grocery stores on Long Island in order to rescue food destined for the dumpster. After gathering mountains of produce, Boone heads to a parking lot in his hometown of Hempstead, where a small army of volunteers joins him in unloading the bounty and packing the food into hundreds of cardboard boxes.
Express Pharma
JUNE 19, 2023
Pharma companies sell their products by representing them to doctors through medical representatives (MRs) and generating prescriptions. These traditional MRs remain the mainstay of a pharma company’s business generation process, even with the emergence of newer modes of connection between healthcare providers and pharma companies, such as digital and omnichannel platforms.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 19, 2023
Cancer patients, like those I treat in San Diego and thousands more across the country, are facing an alarming shortage of critical chemotherapy drugs, forcing oncologists to ration cancer treatment doses for patients with curable diseases. That’s right: If you have cancer right now in the United States, the treatment you need might not be obtainable.
Pharma Times
JUNE 19, 2023
Partnership will help NHS to prepare for fundamental change, including reducing carbon emissions - News - PharmaTimes
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JUNE 19, 2023
Behind a veneer of accomplishment, underneath good grades and musical talents, Emily Chen was in disarray. She never knew what she was missing, perpetually cycling through potential mistakes in her mind in a desperate attempt not to slip up. “I was using anxiety to motivate and power myself. I’d use it as a way to remember things,” said Chen, who lives in Newton, Mass.
Pharmaceutical Technology
JUNE 19, 2023
UK-based pharmaceutical giant GSK has announced that the US Food and Drug Administration (FDA) has extended the review period of its new drug application (NDA) for the rare bone cancer drug momelotinib by three months. The FDA will make an approval decision by the new Prescription Drug User Fee Act (PDUFA) target action date of 16 September 2023. The reason for this review extension was undisclosed in the announcement.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmaceutical Technology
JUNE 19, 2023
Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. The pharma company will in-license a small number of gene therapy products and offer research grants to advance them through pre-clinical development. Laurus Labs will be responsible for launching these products in India and emerging markets.
European Pharmaceutical Review
JUNE 19, 2023
A novel oral ‘robotic pill’ demonstrated a high success rate of drug delivery , according to clinical trial data presented at the Endocrine Society ’s annual meeting (ENDO 2023). “We believe this study provides the first clinical evidence of safe and successful delivery of the osteoporosis drug teriparatide through an oral robotic pill,” stated Arvinder Dhalla, Vice President of Clinical Development at Rani Therapeutics, which was the company that developed the technology.
Pharma Times
JUNE 19, 2023
Vital financing will be used to develop novel therapies for condition with high unmet medical need - News - PharmaTimes
Express Pharma
JUNE 19, 2023
The Indian Institute of Technology Kanpur (IITK) has entered into a Memorandum of Agreement (MOA) with Laurus Labs to introduce gene therapy assets to the market. In accordance with the MOA, IIT Kanpur will transfer several gene therapy assets through in-licensing to Laurus Labs, who will provide a research grant to facilitate their progression through pre-clinical development.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
World Pharma News
JUNE 19, 2023
Cancer cells are even smarter than scientists previously believed, according to new CU Boulder research. When these cells are confronted with potent new drugs called CDK2 inhibitors, which are designed to prevent cancer from proliferating, they can trigger a workaround to survive the assault in as little as one to two hours.
Outsourcing Pharma
JUNE 19, 2023
CStone Pharmaceuticals' shares have risen after academic journal Nature Cancer published the clinical study results of its lung-cancer treatment sugemalimab.
The Pharmacist
JUNE 19, 2023
The community pharmacy sector will require additional funding and resources if it is to successfully deliver on plans for a common conditions service, according to a new report by the Company Chemists’ Association (CCA). The government recently announced £645m investment in community pharmacies in England over the next two years, some of which will be […] The post CCA raises doubts over sector’s capacity to deliver Pharmacy First appeared first on The Pharmacist.
European Pharmaceutical Review
JUNE 19, 2023
A paper published in Scientific Reports has highlighted an effective method for rapid pathogenic fungal identification. While the study of microbiota has been revolutionised by DNA metabarcoding, molecular phylogenetic analysis of fungi is still a challenge, according to the authors. The lack of standardised tools and the incompleteness of reference databases limits the accurate and precise identification of fungal taxa.
pharmaphorum
JUNE 19, 2023
Weight-loss drugs ‘will be a $60bn market in 10 years’ Phil.
Outsourcing Pharma
JUNE 19, 2023
Positive phase 3 results from a trial studying fruquintinib, in patients with previously treated colorectal cancer (CRC) were announced by Hutchmed and Takeda on Friday (June 16).
pharmaphorum
JUNE 19, 2023
Can forecasting help identify market opportunities for pharmaceutical companies? Mike.
Pharmafile
JUNE 19, 2023
Medical dermatology company LEO Pharma has announced that it has appointed Leanne Walsh as its new general manager and vice president for the UK and Ireland, having previously worked as general manager for Northern Europe at Aimmune Therapeutics. Walsh has over 20 years of experience in the pharmaceutical industry at a global, European and affiliate […] The post LEO Pharma appoints Leanne Walsh as general manager and vice president for UK and Ireland appeared first on Pharmafile.
Pharmaceutical Technology
JUNE 19, 2023
Although only a small number of gene therapies have reached the market thus far, the industry is poised to grow quickly over the next few years. Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide.
Drug Patent Watch
JUNE 19, 2023
Annual Drug Patent Expirations for ORAVERSE Oraverse is a drug marketed by Septodont Holding and is included in one NDA. It is available from one supplier. There are three patents… The post New patent expiration for Septodont Holding drug ORAVERSE appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceutical Technology
JUNE 19, 2023
The Chinese patent authority has granted approval for Medivir’s patent application for fostroxacitabine bralpamide (Fostrox). The patent covers substance claims for Fostrox as well as its use to treat liver cancer. It will remain valid until 2035 and is expected to be extended up to five years after that in important markets. The company already holds patents for Fostrox in the EU, Japan, the US and a number of other countries, mainly in Asia.
Pharma Leaders
JUNE 19, 2023
Rosemont Pharmaceuticals has acquired Lucis Pharma, which is a specialist pharmaceutical business in the UK, for undisclosed amount. With the acquisition , Rosemont will expand its existing portfolio and gain access to the new pipeline of products, providing lifesaving pharmaceuticals across the UK and within overseas markets. The acquisition will also allow Rosemont to widen its portfolio and foray into the unit dose or sachet market via the pipeline products and expand its business via recent
Pharmaceutical Business Review
JUNE 19, 2023
With the acquisition , Rosemont will expand its existing portfolio and gain access to the new pipeline of products, providing lifesaving pharmaceuticals across the UK and within overseas markets. The acquisition will also allow Rosemont to widen its portfolio and foray into the unit dose or sachet market via the pipeline products and expand its business via recent Lucis’ product launches in 2021/22.
Pharmaceutical Technology
JUNE 19, 2023
Coherus BioSciences has signed a definitive merger agreement to buy clinical-stage immuno-oncology (I-O) company Surface Oncology, in a deal valued at $65m. The company will buy all outstanding Surface Oncology shares at a price of $5.2831 per share, totalling approximately $40m, along with anticipated net cash of between $20 and $25m. Coherus BioSciences will gain access to Surface Oncology’s two differentiated clinical stage assets, SRF388 and SFR114.
pharmaphorum
JUNE 19, 2023
BMS joins Merck in challenge to Medicare price negotiation Phil.
Pharmaceutical Technology
JUNE 19, 2023
Bio-Thera Solutions and Biomm have entered a licensing and supply agreement for Bio-Thera’s BAT2206, a ustekinumab biosimilar. Biomm will gain exclusive rights for the distribution and marketing in Brazil of the proposed biosimilar to Janssen’s Stelara. Bio-Thera will handle BAT2206’s global development and commercial supply out of its manufacturing plants in Guangzhou, China.
pharmaphorum
JUNE 19, 2023
Festival issues wake-up call for sustainable health Phil.
Outsourcing Pharma
JUNE 19, 2023
A soft mist inhaler made by Resyca BV, a joint venture of Medspray Pharma BV and Recipharm AB, is being brought to patients with pulmonary arterial hypertension (PAH).
FDA Law Blog: Biosimilars
JUNE 19, 2023
By Jeffrey N. Gibbs & Allyson B. Mullen & Gail H. Javitt & McKenzie E. Cato — The long-running saga of FDA regulation of laboratory-developed tests (LDTs) has taken yet another new turn. In the most recent Unified Agenda, which is a list of planned regulatory actions published semi-annually by the Office of Management and Budget (OMB), FDA announced its intent to issue a proposed rule “to make explicit that laboratory developed tests (LDTs) are devices under the Federal Food, Drug,
pharmaphorum
JUNE 19, 2023
AZ may spin off its Chinese business, says report Phil.
PharmaTech
JUNE 19, 2023
Process equipment used in the healthcare and pharmaceutical industries follow rigid specifications for accuracy, consistency and cleanliness.
pharmaphorum
JUNE 19, 2023
BioSenic slumps as it sidelines bone repair therapy Phil.
PharmaShots
JUNE 19, 2023
Shots: Coherus will buy all outstanding Surface Oncology shares by offering its common stock at $5.2831/share resulting in a total transaction value of ~$40M along with anticipated net cash of b/w $20 & $25M Surface shareholders will also receive CVRs for 70% of milestone & royalty-based value from existing partnerships with Novartis & GSK as well as CVRs for 25% of up front for any ex-US rights to SRF114 & 50% for SRF388.
Pharmacy Times
JUNE 19, 2023
Liam Volk, MPharm, president-elect of the Pharmacists’ Defence Association LGBT+ Network, discussed how pharmacists can best support their LGBTQ+ colleagues and patients.
The Guardian - Pharmaceutical Industry
JUNE 19, 2023
UK’s largest stock-market-listed firm weighs up Hong Kong or Shanghai listing to shield it from geopolitical tensions Business live – latest updates AstraZeneca is considering spinning off its business in China and listing it in Hong Kong or Shanghai to shield the multinational drugmaker from geopolitical tensions. Britain’s largest stock-market-listed company has drawn up the plans in attempt to protect its business from the fallout from increasing tensions between China and the US and its alli
Expert insights. Personalized for you.
265 
Let's personalize your content